|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 163.5 USD | +0.48% |
|
+0.58% | +5.56% |
| Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
| Apr. 29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
Health-care companies were more or less flat, but rose on the week after a generally strong batch of earnings.
AbbVie shares slid as sales of blockbuster autoimmune drug Humira continued to fall amid new, lower-cost competition, crimping the drugmaker's earnings.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
04-26-24 1743ET
| 1st Jan change | Capi. | |
|---|---|---|
| +5.56% | 287B | |
| +32.03% | 690B | |
| +26.01% | 546B | |
| -4.64% | 358B | |
| +17.57% | 323B | |
| +14.53% | 235B | |
| +5.64% | 199B | |
| -9.61% | 195B | |
| +4.62% | 161B | |
| -1.65% | 159B |
ABBVIE INC. 
